Bordetella pertussis infection of primary human monocytes alters HLA-DR expression

Infect Immun. 2004 Mar;72(3):1450-62. doi: 10.1128/IAI.72.3.1450-1462.2004.

Abstract

Bordetella pertussis is the causative agent of whooping cough, a potentially lethal respiratory disease in children. In immunocompetent individuals, B. pertussis infection elicits an effective adaptive immune response driven by activated CD4(+) T cells. However, live B. pertussis persists in the host for 3 to 4 weeks prior to clearance. Thus, B. pertussis appears to have evolved short-term mechanisms for immune system evasion. We investigated the effects of B. pertussis wild-type strain BP338 on antigen presentation in primary human monocytes. BP338 infection reduced cell surface expression of HLA-DR and CD86 but not that of major histocompatibility complex class I proteins. This change in cell surface HLA-DR expression reflected intracellular redistribution of HLA-DR. The proportion of peptide-loaded molecules was unchanged in infected cells, suggesting that intracellular retention occurred after peptide loading. Although B. pertussis infection of monocytes induced rapid and robust expression of interleukin-10 (IL-10), HLA-DR redistribution did not appear to be explained by increased IL-10 levels. BP338-infected monocytes exhibited reduced synthesis of HLA-DR dimers. Interestingly, those HLA-DR proteins that were generated appeared to be longer-lived than HLA-DR in uninfected monocytes. BP338 infection also prevented gamma interferon (IFN-gamma) induction of HLA-DR protein synthesis. Using mutant strains of B. pertussis, we found that reduction in HLA-DR surface expression was due in part to the presence of pertussis toxin whereas the inhibition of IFN-gamma induction of HLA-DR could not be linked to any of the virulence factors tested. These data demonstrate that B. pertussis utilizes several mechanisms to modulate HLA-DR expression.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antigen Presentation
  • Antigens, CD / metabolism
  • B7-2 Antigen
  • Bordetella pertussis / pathogenicity*
  • Cell Membrane / immunology
  • HLA-DR Antigens / biosynthesis
  • HLA-DR Antigens / metabolism*
  • Humans
  • In Vitro Techniques
  • Interferon-gamma / pharmacology
  • Interleukin-10 / biosynthesis
  • Interleukin-10 / pharmacology
  • Membrane Glycoproteins / metabolism
  • Monocytes / drug effects
  • Monocytes / immunology*
  • Monocytes / microbiology*
  • Pertussis Toxin / toxicity
  • Recombinant Proteins / pharmacology

Substances

  • Antigens, CD
  • B7-2 Antigen
  • CD86 protein, human
  • HLA-DR Antigens
  • Membrane Glycoproteins
  • Recombinant Proteins
  • Interleukin-10
  • Interferon-gamma
  • Pertussis Toxin